Biocardia Inc (BCDA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.24
• Market Cap: $13.16M
• EPS: $-1.42
• 52-Week High: $3.20
• 52-Week Low: $1.00

Market Sentiment

Biocardia Inc currently has a Bullish sentiment score of 0.30.

About Biocardia Inc

Biocardia, Inc. is a clinical-stage regenerative medicine company headquartered in San Carlos, California, specializing in innovative therapies for cardiovascular diseases. The company focuses on developing advanced cellular therapies and delivery systems designed to enhance patient outcomes in heart conditions, addressing significant unmet medical needs. With a robust pipeline and a commitment to leveraging cutting-edge technologies, Biocardia is strategically positioned for growth as it app...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Biocardia Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BCDA pay dividends?

Biocardia Inc (BCDA) does not currently pay a regular dividend.

What is BCDA's market cap?

Biocardia Inc (BCDA) has a market capitalization of $13.16M with a current stock price of $1.24.